Medical cell technologies for treatment of patients suffering from recessive dystrophic epidermolysis bullosa. Method of intracutaneous administration of fibroblasts

• Prif Awduron: V. I. Albanova (Awdur), A. E. Karamova (Awdur), V. V. Chikin (Awdur), A. A. Mineyeva (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: State Scientific Center of Dermatovenereology and Cosmetology, 2017-08-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited disease developing due to genetic abnormalities in the synthesis of Type VII collagen by fibroblasts. A low production rate of Type VII collagen and abnormalities related to the formation of anchoring fibrils weaken the epidermi...